ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633271 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633271; 2) Community: the network communities that were significantly associated with the response to NSC 633271; 3) Molecule: the relationships between components within communities and NSC 633271; 4) MDR: the compounds that were significantly associated with the NSC 633271.

NSC Compound Enrichment Correlation
NSC 348402 Null 0.0203119150246193 0.32749924
NSC 5355 Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium, 5,6-dihydro-9,10-dimethoxy-, sulfate (2:1) (9CI) 0.0203119150246193 0.23532257
NSC 645016 Null 0.0203119150246197 0.32710475
NSC 645305 Null 0.0203119150246197 0.063282437
NSC 717956 Null 0.0203119150246197 0.15011735
NSC 724065 (3,5-dibromo-2-hydroxy-benzylidene-hydrazinocarbonylmethylsu lfanyl)acetic acid (3,5-dibromo-2-hydroxy-benzylidene)-hydrazide 0.0203119150246197 0.21443255
NSC 741289 5-[(3-hydroxy-4-methoxyphenyl)ethynyl]-6-(3,4,5-trimethoxyphenyl)-2H-pyran-2-one 0.0203119150246197 0.38153405
NSC 111533 Methoxycamptothecin 0.0209467683758282 -0.017116323
NSC 255105 GELDANAMYCIN ANALOG 0.0209467683758282 0.48656213
NSC 269599 Stannane, chlorohydroxydiphenyl- 0.0209467683758282 0.45732205
Total:75  Current:34    [First] [Prev] [Next] [Last]